Trump Faces First Hearing Over Whether He Can Run For President Today—What To Watch For In 14th Amendment Case
As RSV season approaches, some doses of nirsevimab—the monoclonal antibody RSV immunization for infants—are in a limited supply, so the CDCshot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease.on October 23 about a shortage of 100 milligram doses of nirsevimab , which are typically given to infants weighing over 11 pounds — though 50 milligram dose supplies aren’t affected.
While 50 milligram doses are not affected by the shortage, the CDC warns doctors not to combine two 50 milligram doses; the smaller doses are intended for infants weighing 11 pounds or less, and the CDC wants to avoid a secondary shortage.